Product Information
LYUMJEV 200 UNIT/ML KWIKPEN is a brand product labeled by Eli Lilly and Company, priced at $20.3060 per ML under NDC 00002822827. Its NADAC has been published 175 times since Nov 23, 2022.
Strength
200 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002822827
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA761109On Market Since
6/15/2020
Pharmacological Classes
Price Statistics
The NADAC for LYUMJEV 200 UNIT/ML KWIKPEN has been published 175 times since Nov 23, 2022, and over the history we have for it it has declined 70.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.3060 per ML |
|---|---|
| All-time high | $67.9496 (Dec 11, 2024) |
| All-time low | $20.3060 (Jun 17, 2026) |
| 52-week high | $67.8112 |
| 52-week low | $20.3060 |
| Median price | $67.7254 |
| Average price | $61.7860 |
| Largest weekly change | -70.0% (Jan 28, 2026) |
| Weeks tracked | 175 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Insulin lispro-aabc market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LYUMJEV 200 UNIT/ML KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for LYUMJEV 200 UNIT/ML KWIKPEN, manufactured by Eli Lilly and Company, is $20.3060 per ML (NDC 00002822827), effective Jun 24, 2026.
How has the price of LYUMJEV 200 UNIT/ML KWIKPEN changed over time?
Over the history we have for it, the NADAC for LYUMJEV 200 UNIT/ML KWIKPEN has declined 70.0%. It has been tracked across 175 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for LYUMJEV 200 UNIT/ML KWIKPEN?
Since Nov 23, 2022, the NADAC for LYUMJEV 200 UNIT/ML KWIKPEN has ranged from a low of $20.3060 (Jun 17, 2026) to a high of $67.9496 (Dec 11, 2024), with a median of $67.7254 per ML.
Are there cheaper alternatives to LYUMJEV 200 UNIT/ML KWIKPEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LYUMJEV 200 UNIT/ML KWIKPEN, so no direct lower-cost alternative is listed.
Who manufactures LYUMJEV 200 UNIT/ML KWIKPEN?
LYUMJEV 200 UNIT/ML KWIKPEN (NDC 00002822827) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification